课题基金 / 基金详情

Real-Time Blood Propofol Monitoring

Real-Time Blood Propofol Monitoring
实时血液异丙酚监测
批准号:
133875
负责人:
金额:
$43.05万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Propofol is an intravenous drug used to induce general anaesthesia (unconsciousness or drug induced sleep). It can also be administered by continuous infusion to keep the patient asleep and has substantial benefits for patients compared with the use of anaesthetic gases. These benefits include a carefully controlled, smooth induction of anaesthesia and a rapid, high quality recovery with a very low incidence of nausea. Propofol has less impact on memory, especially in susceptible patients. Patients who have cancer and are anaesthetised with propofol are more likely to be alive 5 years later than those given gaseous anaesthesia. Emerging laboratory evidence is helping to explain this.There are benefits to the anaesthetist too. Some patients cannot be anaesthetised with a gas whilst equipment or environmental concerns prevent its use in others. The anaesthetist has no worries about the patient awakening during a difficult instrumentation of the airway (during which a gas cannot be delivered).Propofol infusions are also used extensively to sedate patients (make them calm and sleepy but still responsive) such as those in intensive care units.During gaseous anaesthesia the gas can be measured in the patient's breath, this shows that it is being delivered to the patient as well offering a measurement of how much is in their system. During intravenous anaesthesia it would be ideal if the amount of propofol in the blood could be monitored and displayed continuously. Such a 'real-time' monitor does not currently exist. Blood propofol concentrations can be measured by sending samples to a laboratory but the delay means that this does not meet the anaesthetist's need for immediate and continuous information.A real-time blood propofol monitor would increase patient safety by:* Providing evidence that the drug is being delivered to the patient (and thus a rapid indication of an accidentally disconnected infusion line).* Indicating how deeply the patient is anaesthetized or sedated* Refining the dosing calculations built into anaesthetic infusion pumps* Moving toward personalised anaesthesia by adjusting drug doses to individual patientsThis application is being made to support the development of a functioning prototype real-time blood propofol measuring system that works in a laboratory. Required milestones include the invention of a sensor that detects propofol at clinically relevant concentrations, integrating it into a recovery system for use in blood, and linking it to a data display. Further work will be required to produce a clinically useful monitor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
SERS探针诱导TAM重编程调控头颈鳞癌TIME的研究
  • 批准号:
    82360504
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    周学军
  • 依托单位:
华蟾素调节PCSK9介导的胆固醇代谢重塑TIME增效aPD-L1治疗肝癌的作用机制研究
  • 批准号:
    82305023
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王萌
  • 依托单位:
基于MRI的机器学习模型预测直肠癌TIME中胶原蛋白水平及其对免疫T细胞调控作用的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    李文政
  • 依托单位:
结直肠癌TIME多模态分子影像分析结合深度学习实现疗效评估和预后预测
  • 批准号:
    62171167
  • 项目类别:
    面上项目
  • 资助金额:
    57万元
  • 批准年份:
    2021
  • 负责人:
    姜慧杰
  • 依托单位: